
Opinion|Videos|August 15, 2023
Triplet Regimens for First-Line Advanced Renal Cell Carcinoma
Author(s)Rana R. McKay, MD
Discussion on triplet therapy regimens in advanced RCC and how progressing therapeutic studies can impact its future use.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5









































